Related Experiment Video

Updated: Jun 25, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
09:08

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028

Published on: January 13, 2017

The Kdo biosynthetic pathway toward OM biogenesis as target in antibacterial drug design and development

Laura Cipolla1, Alessandra Polissi, Cristina Airoldi

  • 1Department of Biotechnology and Biosciences, University of Milano-Bicocca, P.za della Scienza 2, 20126 Milano, Italy. laura.cipolla@unimib.it

Current Drug Discovery Technologies
|March 12, 2009
PubMed

Insights

New strategies targeting Kdo biosynthesis offer a promising approach to combat antibiotic-resistant bacteria. Inhibiting this essential pathway in Gram-negative bacteria could lead to broad-spectrum antibacterial treatments.

Area of Science:

  • Microbiology
  • Drug Discovery
  • Biochemistry

Background:

  • Infectious diseases remain a significant global health threat, exacerbated by rising antibiotic resistance.
  • Traditional antibiotics target essential bacterial processes but face challenges from evolving resistance mechanisms.
  • Developing novel antibacterial agents is crucial to address the growing threat of pathogenic microorganisms.

Purpose of the Study:

  • To review therapeutic strategies for infectious diseases caused by Gram-negative bacteria.
  • To explore the development of inhibitors targeting Kdo (2-keto-3-deoxy-D-mannose) biosynthesis.
  • To highlight the potential of Kdo biosynthesis inhibitors as broad-spectrum antibacterial agents.

Main Methods:

  • Literature review of current research on Kdo biosynthesis and its role in bacterial outer membrane biogenesis.
  • Analysis of traditional antibiotic discovery approaches and their limitations.
  • Evaluation of Kdo biosynthesis as a novel target for antibacterial drug development.

Main Results:

  • Kdo is a unique monosaccharide essential for the biogenesis of the outer membrane in Gram-negative bacteria.
  • Inhibiting Kdo biosynthesis disrupts outer membrane integrity, leading to bacterial cell death.
  • Targeting Kdo biosynthesis presents a viable strategy for developing new antibacterial drugs.

Conclusions:

  • Inhibitors of Kdo biosynthesis represent a promising therapeutic avenue against Gram-negative bacterial infections.
  • This approach offers potential for broad-spectrum activity, addressing the challenge of antibiotic resistance.
  • Further research into Kdo biosynthesis inhibitors is warranted for novel drug discovery.

More Related Videos

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli10:41

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli

Published on: January 13, 2013

Related Concept Videos

Biosynthesis in Bacteria01:24

Biosynthesis in Bacteria

Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...